IDMP is not just another regulation, it is the primary standard that will underpin multiple future regulations and industry initiatives. In terms of public health, improved visibility into the spread ...

Even now, after a decade of run-up, pharma’s readiness to implement and harness ISO IDMP standards still varies wildly, as does companies’ relative maturity in supporting FAIR data principles, geared ...

Many pharmaceutical companies are sceptical about IDMP despite the business benefits and its contribution to patient safety. The European Union is aiming to play a big role in the creation of a global ...

The global response to COVID-19 has shone a light on the broader potential for global data standards, including those defined via the International Organization for Standardization (ISO) ...

How pharma firms assess their readiness for IDMP (Identification of Medicinal Products) is important for meeting compliance requirements and ensuring they are prepared for the digital product ...

Lise Stevens explores what difference the ISO IDMP (Identification of Medicinal Products) data standards would have made in a COVID-19 context — in applications ranging from pharmacovigilance adverse ...

Momentum and vision around IDMP must be maintained in 2020 if standardised medicinal product data is to be of tangible real-world benefit A huge amount of investment has gone into preparations for the ...

The European Medicines Agency (EMA) has recently published the second version of its EU IDMP Implementation Guide, and it is a landmark regulation for software vendors and pharma companies alike. This ...

Substantial investment has gone into the preparations for the EU’s implementation of the ISO IDMP (identification of medicinal products) standards, which must not be compromised in 2020 - whatever the ...